Stephen G. Dilly
Overview
Stephen G. Dilly received $8M in total compensation, including $350K in salary, at ProNAi Therapeutics in 2020. Stephen Dilly also received an average of $3M at Aimmune Therapeutics from 2014 to 2018.
- 2020
- 2018
- 2017
- 2016
- 2015
- 2014
ProNAi TherapeuticsPresident and Chief Executive Officer
Aimmune TherapeuticsFormer Chief Executive Officer
Aimmune TherapeuticsChief Executive Officer
Aimmune TherapeuticsChief Executive Officer
Aimmune TherapeuticsChief Executive Officer
Aimmune TherapeuticsChief Executive Officer
Source: SEC filings on April 23, 2021, April 10, 2019, April 11, 2018, and April 12, 2016.
Related executives
We found 15 more executives who work or worked at ProNAi Therapeutics and Aimmune Therapeutics.
Nick Glover
ProNAi Therapeutics
Chief Executive Officer
Barbara Klencke
ProNAi Therapeutics
Chief Development Officer
Mark Kowalski
ProNAi Therapeutics
Chief Medical Officer
Jayson Dallas
Aimmune Therapeutics
Chief Executive Officer
Andrew Oxtoby
Aimmune Therapeutics
Chief Commercial Officer
Eric Bjerkholt
Aimmune Therapeutics
Chief Financial Officer
Douglas Sheehy
Aimmune Therapeutics
General Counsel
Daniel Adelman
Aimmune Therapeutics